Skip to content

Chlamydia pneumoniae IgG ELISA Kit ESR1371G

$334.00

Summary

  • Virion/Serion Diagnostic Kit for research use (RUO)
  • Chlamydia pneumoniae IgG ELISA Kit
  • Suitable for IgG detection
  • Ready-to-use
  • 96 tests

Order now and receive on May 30, 2024

Calculate shipping price

Please fill in the fields below with the shipping destination details in order to calculate the shipping cost.

Weight1 lbs
Dimensions9 × 5 × 2 in
target

Chlamydia pneumoniae reactive IgG

species reactivity

Chlamydia pneumoniae

applications

ELISA

assay type

Indirect & quantitative

available sizes

96 tests

kit
Assay type
Indirect ELISA
Research area
Infectious Disease
Sample type
Serum, plasma, whole blood
Notes
Pretreatment of samples with RF-Absorbent (Z200) is recommended for use with IgM ELISA kits to eliminate presence of sample rheumatoid factors and possible false negative results.
Components
Break apart microtiter test strips each with antigen coated single wells8 x 12 (96 Total)
Standard serum (ready-to-use)2 x 2 mL
Negative control serum (ready-to-use)2 mL
Anti-human-IgG-conjugate (ready-to-use)13 mL
Washing solution concentrate (sufficient for 1000ml)33.3 mL
Dilution buffer2 x 50 mL
Stopping solution15 mL
Substrate (ready-to-use)13 mL
Quality control certificate with standard curve and evaluation table1
Storage
Store at 2-8°C.
Associated products
Chlamydia trachomatis EB + RB Antigen (BA1372VSER)
Chlamydia trachomatis MOMP Antigen (BA1372VSR2)
Chlamydia trachomatis IgA Control Serum (BC1372A)
Chlamydia trachomatis IgG Control Serum (BC1372G)
Chlamydia trachomatis IgM Control Serum (BC1372M)
Chlamydia trachomatis IgA ELISA Kit (ESR1372A)
Chlamydia trachomatis IgG ELISA Kit (ESR1372G)
Chlamydia trachomatis IgM ELISA Kit (ESR1372M)
Chlamydia IgA ELISA Kit (ESR137A)
target relevance
Organism
Chlamydia pneumoniae
Structure and strains
Chlamydia pneumoniae is a species of Chlamydia, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Briefly, it was known as Chlamydophila pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given.
Disease
Chlamydiae are gram-negative, obligat intracellular bacteria. Characteristically, the chlamydial cell wall lacks a peptidoglycan layer. Only the species Chlamydia trachomatis, Chlamydia pneumoniae (also referred to as Chlamydophila pneumoniae) and Chlamydia psittaci (also referred to as Chlamydophila psittaci) are relevant to human disease.

Chlamydia pneumoniae is an airborne pathogen spread by inhaled droplets. Infections with C. pneumoniae are often asymptomatic or mild. The spectrum of clinical symptoms comprises pharyngitis, sinusitis, bronchitis, pneumonia and myocarditis or endocarditis. Infection may occasionally lead to chronic disease resulting in immunopathological syndromes such as erythema nodosum, arthralgia, Guillain-Barre Syndrome (GBS), or myalgia. In addition, chronic infections with C. pneumoniae are implicated with the etiology of asthma, COPD, atherosclerosis and cardiovascular disease. Approximately 10% of all cases of pneumonia as well as around 5% of infections of the upper respiratory tract are caused by Chlamydia pneumoniae. Diagnosis
Detection and diagnosis
Diagnosis of a Chlamydia pneumoniae infection is usually based on serological analysis by detection of specific serum antibodies. In the past, the microimmunofluorescence (MIF) test has been used as a reference method. However, it is increasingly replaced by species-specific ELISA tests, which allow for better standardization and automation. Seroprevalence rates rise rapidly in preschool age and reaches >50% after adolescence. Later on in life, the prevalence of C. pneumoniae increases even further due to frequently reoccurring infections and due to its propensity to lead to chronic disease. Beyond 65 years of age, seroprevalence may reach 70-100%. Seroprevalence rates for IgA are barely lower (approximately 60-70%) than for IgG

Data

Publications

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

pmidtitleauthorscitation

Protocols

relevant to this product
ESR1371G protocol

Documents

#
No results found

Reviews

There are no reviews yet.

Be the first to review “Chlamydia pneumoniae IgG ELISA Kit ESR1371G”